Díaz-Manera J - Search Results

1

The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.

Cortés-Vicente E, Rojas-Garcia R, Díaz-Manera J, Querol L, Casasnovas C, Guerrero-Sola A, Muñoz-Blanco JL, Bárcena-Llona JE, Márquez-Infante C, Pardo J, Martínez-Fernández EM, Usón M, Oliva-Nacarino P, Sevilla T, Illa I. Cortés-Vicente E, et al. Ann Clin Transl Neurol. 2018 Apr 14;5(6):710-716. doi: 10.1002/acn3.564. eCollection 2018 Jun. Ann Clin Transl Neurol. 2018. PMID: 29928654 Free PMC article.

2

["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series].

Illa I, Díaz-Manera JA, Juárez C, Rojas-García R, Molina-Porcel L, Aleu A, Pradas J, Gallardo E. Illa I, et al. Med Clin (Barc). 2005 Jun 18;125(3):100-2. doi: 10.1157/13076937. Med Clin (Barc). 2005. PMID: 15989843 Spanish.

3

A novel antiganglioside specificity against terminal NeuNAc(alfa 2-3)Gal in acute bulbar palsy.

Rojas-Garcia R, Martinez-Lage M, Gallardo E, de Luna N, Marti-Vilalta JL, Diaz-Manera J, Juarez C, Blesa R, Illa I. Rojas-Garcia R, et al. J Neuroimmunol. 2006 Jul;176(1-2):219-22. doi: 10.1016/j.jneuroim.2006.04.001. Epub 2006 May 16. J Neuroimmunol. 2006. PMID: 16707165

4

Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.

Díaz-Manera J, Rojas-García R, Gallardo E, Juárez C, Martínez-Domeño A, Martínez-Ramírez S, Dalmau J, Blesa R, Illa I. Díaz-Manera J, et al. Nat Clin Pract Neurol. 2007 Jul;3(7):405-10. doi: 10.1038/ncpneuro0526. Nat Clin Pract Neurol. 2007. PMID: 17611489

5

Antibodies against disialosyl and terminal NeuNAc(alpha2-3)Gal ganglioside epitopes in acute relapsing sensory ataxic neuropathy.

Rojas-Garcia R, Gallardo E, Povedano M, de Luna N, Bruna J, Juarez C, Diaz-Manera J, Martinez-Matos JA, Illa I. Rojas-Garcia R, et al. J Neurol. 2008 May;255(5):764-6. doi: 10.1007/s00415-008-0803-0. Epub 2008 Mar 17. J Neurol. 2008. PMID: 18344054 No abstract available.

6

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.

Illa I, Diaz-Manera J, Rojas-Garcia R, Pradas J, Rey A, Blesa R, Juarez C, Gallardo E. Illa I, et al. J Neuroimmunol. 2008 Sep 15;201-202:90-4. doi: 10.1016/j.jneuroim.2008.04.039. Epub 2008 Jul 23. J Neuroimmunol. 2008. PMID: 18653247

7

Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient.

Díaz-Manera J, Rojas-García R, Gallardo E, Illa I. Díaz-Manera J, et al. Muscle Nerve. 2009 Mar;39(3):386-8. doi: 10.1002/mus.21171. Muscle Nerve. 2009. PMID: 19208395

8

Treatment strategies for myasthenia gravis.

Díaz-Manera J, Rojas-García R, Illa I. Díaz-Manera J, et al. Expert Opin Pharmacother. 2009 Jun;10(8):1329-42. doi: 10.1517/14656560902950619. Expert Opin Pharmacother. 2009. PMID: 19445561 Review.

9

Unique post-exercise electrophysiological test results in a new Andersen-Tawil syndrome mutation.

Díaz-Manera J, Querol L, Clarimón J, Yagüe S, Illa I. Díaz-Manera J, et al. Clin Neurophysiol. 2011 Dec;122(12):2537-9. doi: 10.1016/j.clinph.2011.04.025. Epub 2011 Jun 2. Clin Neurophysiol. 2011. PMID: 21640645 No abstract available.

10

Treatment strategies for myasthenia gravis: an update.

Díaz-Manera J, Rojas García R, Illa I. Díaz-Manera J, et al. Expert Opin Pharmacother. 2012 Sep;13(13):1873-83. doi: 10.1517/14656566.2012.705831. Epub 2012 Jul 9. Expert Opin Pharmacother. 2012. PMID: 22775575 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page